Myths about HSCT for MS

This guide aims to dispel common myths and misconceptions surrounding Haematopoietic Stem Cell Transplantation

(HSCT) for Multiple Sclerosis (MS) patients in the UK and overseas. Using data and evidence, we clarify misunderstandings

and provide MS patients with accurate information to make informed decisions about this complex treatment option.